Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceutical Stock Could Double | Barron's
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate' | Markets Insider
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
FDA approves first generic version of epilepsy drug Sabril from Teva
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
teva News and latest stories | The Jerusalem Post
teva News and latest stories | The Jerusalem Post
Teva Pharmaceuticals, News And Latest Headlines - I24NEWS
Buy Teva Pharmaceuticals amid positive news, Bernstein says
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
TEVA Stock Alert: What to Know About Teva Pharmaceuticals' New CEO | InvestorPlace
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
